U.S. Medical Equipment Stock News

NYSE:BABA
NYSE:BABAMultiline Retail

Alibaba (BABA) Stock Trades Below Fair Value Despite AI Push

Alibaba Group Holding has seen its share price come under pressure this year, and the question for you as an investor is whether the current US$108.54 level is still supported by the cash the business can generate over time. With fresh headlines around its artificial intelligence efforts and legal challenges, the gap between news flow and cash flow has become harder to ignore. Over the past 3 years the stock has delivered a 37.0% gain, which puts the spotlight firmly on whether that kind of...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Energy (ES) Wins TIDE Project, Is The Stock Still 7% Undervalued?

Eversource Energy (ES) just picked up a major assignment in New England. ISO New England selected its Transmission Initiative Down East project to expand regional grid capacity and support onshore wind integration. At a share price of US$68.99, Eversource Energy has seen a 1-day share price return of 1.67%, while the 30-day share price return is down 4.47% and the year to date share price return is up 1.37%. The 1-year total shareholder return of 12.94% and 3-year total shareholder return of...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

BBB Foods (TBBB) Could Be 2% Undervalued Following Strong Q2 Growth

Fresh Q2 2026 numbers put BBB Foods (NYSE:TBBB) in focus after revenue grew 39% year over year and same store sales rose 20%, alongside 155 new stores and an expanded distribution network. The Q2 update follows a strong run for BBB Foods, with the share price at $50.9 and a year-to-date share price return of 48.09%. The 1-year total shareholder return of 96.75% suggests that momentum has been building rather than fading. Scan beyond BBB Foods and see how other consumer stocks with strong...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Why Bitdeer (BTDR) Is Up 14.1% And What's Next After AI Cloud Expansion

Bitdeer Technologies Group reported August 2026 production results that showed 84.1 EH/s of hash rate under management and 1,310 Bitcoins mined, alongside a new 10-year data center services agreement for its 65.1MW A202 AI Cloud facility in Johor Bahru, Malaysia. The A202 agreement, combined with the existing A201 site, indicates that Bitdeer Technologies Group is building a sizable AI Cloud campus. The company is aiming to fund GPU deployment largely through customer prepayments and...
NYSE:INSW
NYSE:INSWOil and Gas

International Seaways (INSW) As Record Q2 Tanker Earnings Meet An Overvalued View

International Seaways (INSW) has just posted record second quarter net income, with tanker earnings tied to higher time charter equivalent revenues as Middle East chokepoint disruptions push vessels onto longer crude and product routes. At a share price of US$110.53, International Seaways has ridden strong tanker markets into sharp near term momentum, with a 7 day share price return of 8.21% and a 90 day move of 30.82%. Long term investors have seen a 1 year total shareholder return of...
NYSE:ICL
NYSE:ICLChemicals

Is ICL Group (ICL) Undervalued As Its Earnings Upgrade Lifts Expectations?

ICL Group (NYSE:ICL) is back on radars after a recent upgrade to a stronger Zacks rank, driven by higher earnings estimates that point to improved expectations and fresh scrutiny of the stock. Recent trading tells a mixed story for ICL Group. The US$5.53 share price follows a 7.59% return over the past 90 days, while the 1-year total shareholder return is down 7.18%. This suggests that recent momentum is improving from a weaker longer-term base as the earnings upgrade renews interest in the...
NYSE:URI
NYSE:URITrade Distributors

United Rentals (URI) Heads To Laguna, Is A 21% Undervalued View Enough?

United Rentals (URI) heads into Morgan Stanley's 14th Annual Laguna Conference on 15 September with both its chief executive and finance chief scheduled to speak, drawing fresh attention to the equipment rental specialist. United Rentals enters the conference after a mixed stretch for the share price, with the stock down about 10.2% over the past 30 days and 6.9% over 90 days, even as the year-to-date share price return is 18.63% and the 3-year total shareholder return is 136.46%. This...
NasdaqGS:HBNC
NasdaqGS:HBNCBanks

Horizon Bancorp (HBNC) Could Be 15% Undervalued After Its Dividend Update

Horizon Bancorp (HBNC) has reaffirmed its shareholder payout policy. On 15 September 2026, the board approved a US$0.16 per share dividend, scheduled for payment on 16 October to investors of record on 2 October. Horizon Bancorp’s dividend decision lands after a mixed few months for the stock, with a 30-day share price return of 3.75% in decline, but a year-to-date share price gain of 18.02% and a 1-year total shareholder return of 20.28% signalling that momentum has been building over a...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

PTC (PTC) Lands Enterprise Wide Defense Engineering Rollout With Major Customer

PTC (NasdaqGS:PTC) has been selected by Fisica Applied Technologies Inc. for enterprise-wide use of Creo and Windchill. The agreement covers product design and lifecycle management across multiple Fisica defense programs and geographically dispersed operations. The rollout is intended to standardize digital engineering workflows for complex, mission-critical defense systems at Fisica. The Fisica decision to adopt PTC Creo and Windchill only tells part of the story for investors. We have also...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc (TDOC) Stock May Trade At A 44% Discount After Soft Q2 Results

Teladoc Health has seen its share price fall a long way over the past few years, and the market is now effectively asking whether the current US$6.28 level can be justified by the cash the business is expected to generate. With the stock still reacting to recent news, the key issue for you is whether the cash flow outlook lines up with what the market is paying today. The share price has declined about 95.5% over 5 years, which puts the focus squarely on whether the remaining equity value is...
NYSE:DOCN
NYSE:DOCNIT

Why Did DigitalOcean Holdings (DOCN) Climb After Its Latest Update?

DigitalOcean Holdings (DOCN) is back in focus after securing a new $725 million equipment finance facility to scale its AI infrastructure, paired with the launch of its Managed AI Agents product. The recent $725 million facility and AI push have arrived after a sharp run, with DigitalOcean Holdings’ share price up 171.55% year to date and a 1-year total shareholder return of 257.38%. However, the 90-day share price return shows a 23.25% pullback that hints at cooling momentum before this...
NYSE:CCI
NYSE:CCISpecialized REITs

Is Crown Castle (CCI) Undervalued Following The Analyst Upgrade On Earnings Estimates?

Executive changes and earnings sentiment around Crown Castle Fresh optimism around Crown Castle (CCI) has been sparked by an analyst upgrade tied to higher earnings estimates, putting the spotlight on how these expectations line up with recent leadership moves. The rating shift reflects revised profit forecasts that some investors see as a signal of confidence in the business. It arrives as Crown Castle prepares for a measured transition in senior finance and operating roles over the next...
NasdaqGM:TTD
NasdaqGM:TTDMedia

What Does Trade Desk (TTD) Gain From Its New Pharma Analytics Push?

Trade Desk (NasdaqGM:TTD) expanded its healthcare-focused partnerships with Veeva Crossix and IQVIA Digital, adding deeper analytics for pharma advertisers. The integrations are designed to give pharmaceutical brands more granular measurement of campaign performance across digital channels. Real-time audience analysis and in-flight optimization tools are being made available to help drug makers adjust spend while campaigns are running. The expanded Veeva Crossix and IQVIA Digital...
NYSE:MPT
NYSE:MPTHealth Care REITs

Medical Properties Trust (MPT) Stock Looks Undervalued After Asset Sale Plans

Medical Properties Trust has seen a prolonged share price slide, and that kind of track record pushes the focus squarely onto what its current price implies about the cash the business can generate. With the stock now trading around the mid single digits, the obvious question is whether the recent valuation still lines up with the cash flows its hospitals portfolio can realistically support. Over the past 5 years the share price has fallen 73.6%, which puts the spotlight on whether investors...
NYSE:PBI
NYSE:PBICommercial Services

Is Pitney Bowes (PBI) Undervalued Or Is Its Rally Already Priced In?

Pitney Bowes (PBI) has drawn fresh attention after Zacks assigned the stock its highest rating and a strong Value grade, highlighting its current valuation metrics and earnings outlook for investors. Pitney Bowes shares have climbed sharply over 2026, with a year to date share price return of 67.67% and a 1 year total shareholder return of 53.86%. The very large 3 year total shareholder return suggests that recent momentum has built on earlier gains, despite a slight 90 day pullback. Scan how...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Does Sandisk (SNDK) Risk Losing Ground In AI Memory As New NAND Supply Emerges?

Sandisk (NasdaqGS:SNDK) faces a new rival as China's CXMT prepares to enter the NAND flash market focused on AI customers. CXMT is building a dedicated NAND R&D line and is already in talks with major AI hardware buyers about supply plans. The move would create a second large Chinese NAND supplier, expanding domestic capacity and reshaping global memory supply structures. CXMT's push into NAND for AI workloads changes the competitive backdrop that frames Sandisk's long term positioning in...
NYSE:PRU
NYSE:PRUInsurance

Prudential Financial (PRU) Is Getting Attention, What Is Behind Its Latest Update?

Prudential Financial (PRU) has laid out a multi year overhaul of its business mix, narrowing its geographic footprint, exiting selected emerging markets, and planning to redeploy more than US$3b of capital. Recent trading shows a mixed picture for Prudential Financial, with the share price up 10.7% over 90 days but down 5.3% over the past month, while the 1 year total shareholder return of 19.6% signals stronger results for investors who held through the past year. The current share price of...
NYSE:A
NYSE:ALife Sciences

Is FDA Cleared Scanner Launch Altering The Investment Case For Agilent Stock?

Agilent Technologies has launched the FDA cleared S540MD Slide Scanner System in the U.S., a high throughput digital pathology platform that can process up to 540 slides with continuous loading and automated tissue detection. The scanner extends Agilent Technologies' push into digital pathology. It targets clinical labs looking to handle heavier sample volumes while preparing for AI enabled diagnostic workflows across major U.S. and European markets. This article examines how Agilent...
NasdaqGS:LZ
NasdaqGS:LZProfessional Services

AI Rules Could Lift Demand For Insperity Stock And Other Compliance Services Shares

AI just met its first serious speed bump in California, and that could quietly reshape who makes money from the boom. As frontier developers brace for kill switches, audits, and heavier oversight, demand for legal, consulting, and compliance expertise linked to AI governance is getting harder to ignore. This article unpacks that shift and profiles 3 US-listed professional-services stocks exposed to these AI regulation themes. The three stocks below are a sample pulled from a wider screen,...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Sterling Infrastructure (STRL) Stock Looks Like A Cash Flow Bargain

Sterling Infrastructure has been on a powerful multi‑year run, and that kind of track record naturally raises a question for you as an investor. Is the current share price still aligned with the cash flows the business is expected to generate, or has the story run ahead of the underlying money coming in the door? Over 5 years, Sterling Infrastructure has delivered a very large total return of about 22x, which puts a lot of weight on whether its cash flows can keep backing up that kind of...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

Does Third Point Stake Change The Bull Case For TTM Technologies Stock (TTMI)?

TTM Technologies has completed a private offering of US$500 million in 6.750% senior unsecured notes due 2034, alongside plans for additional term loan financing. Together, these funding sources are intended to support the proposed acquisitions of Epiq Solutions and Swiss Technology Group and cover related corporate uses. Activist investor Dan Loeb's Third Point has taken a stake in TTM Technologies, which raises questions about potential shifts in capital allocation, acquisition priorities,...
NasdaqGM:BRUN
NasdaqGM:BRUNIT

Boost Run (BRUN) Stock Could Still Be Cheap Given Its Sales Outlook

Boost Run has delivered a sharp share price move over the past year, which puts fresh focus on a simple question for investors. Is the current US$16.68 price tag adequately grounded in the sales the business is generating today and is expected to produce next? Boost Run has gained 45.0% over the past year, which raises the stakes on whether recent enthusiasm is properly supported by its sales base. The company’s ability to convert top line growth into durable revenue and cash generation can...
NYSE:RCUS
NYSE:RCUSBiotechs

Is Arcus Biosciences (RCUS) Priced For More Than Current Sales?

Arcus Biosciences has seen its share price move sharply over the past year, which puts fresh attention on whether the current valuation is supported by the revenue the business is generating today. With the stock now trading at US$25.54, the key issue is how that market value lines up against its sales profile. The share price has gained 105.3% over the past 12 months, so anyone looking at Arcus Biosciences now is effectively asking whether that move is still grounded in its revenue...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

How $244 Million Shelf Filing Will Impact Zenas BioPharma (ZBIO) Stock

Zenas BioPharma filed two shelf registrations on 11 September 2026 covering up to 7,600,000 common shares, totaling about $244.69 million, including an $18.66 million ESOP-related component. The combined size of these potential offerings highlights a meaningful focus on future funding flexibility, which could influence how investors view Zenas BioPharma’s capital needs and cost base. This article examines how Zenas BioPharma’s investment narrative may be affected by this large shelf capacity...